SEDASLEEP

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

Passiflora incarnata, Quantity: 125 mg (Equivalent: Passiflora incarnata, Qty 500 mg); Humulus lupulus, Quantity: 23.34 mg (Equivalent: Humulus lupulus, Qty 175 mg)

Commercializzato da:

Bioplus Healthcare Pty Ltd

Forma farmaceutica:

Tablet, uncoated

Composizione:

Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; maltodextrin; crospovidone; lecithin

Via di somministrazione:

Oral

Indicazioni terapeutiche:

Traditionally used in Western herbal medicine to Decrease/reduce/relieve restlessness/excess nervous energy ; Traditionally used in Western herbal medicine to Decrease/reduce/relieve nervous tension/unrest ; Traditionally used in Western herbal medicine to Calmative/nervous system relaxant ; Traditionally used in Western herbal medicine to Nervine/support nervous system ; Traditionally used in Western herbal medicine to Soporific/induces sleep ; Traditionally used in Western herbal medicine to Decrease/reduce/relieve sleeplessness ; Traditionally used in Western herbal medicine to Decrease/reduce/relieve disturbed/restless sleep

Dettagli prodotto:

Visual Identification: ;

Stato dell'autorizzazione:

Listed

Data dell'autorizzazione:

2020-12-11